Tenaya Therapeutics to participate in September investor conferences
Tenaya Therapeutics announced it will participate in upcoming September investor conferences. The company is a clinical-stage biotech focused on therapies targeting heart disease underlying causes.
SOUTH SAN FRANCISCO, Calif., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc.
NASDAQ:TNYA, a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Comp…